Author

Hsiao-Lin Lee

Primary ORCID profile (0000-0002-4828-3383 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Hsiao-Lin LeeiD1 paper · National Taiwan University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alfur Fu-Hsin Hung· 1 shared Birthe B. Kragelund· 1 shared Chi-Fon Chang· 1 shared Chih-Neng Hsu· 1 shared Chu-Hsuan Chiu· 1 shared Chun-Mei Hu· 1 shared Daniel Laio· 1 shared Daniel Saar· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Alfur Fu-Hsin Hung

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of PTGR2 inhibitors as a new therapy for diabetes and obesity

Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, Siow-Wey Hee, Chi-Fon Chang, Hsin-Yung Yen, Yi-An Chen, Yet-Ran Chen, Ya-Wen Chou, Fu-An Li, Yi-Yu Ke, Shih-Yi Chen, Ming-Shiu Hung, Alfur Fu-Hsin Hung, Jing-Yong Huang, , Lee-Ming Chuang

The paper identifies PTGR2 inhibitors as a new therapy for diabetes and obesity by improving glucose homeostasis and preventing diet-induced obesity without side effects.

bioRxiv · Dec 17, 2024 · PreprintPhysiology